Clay Siegall’s contribution to cancer therapy

As the co-founder of Seattle Genetics, Dr Siegall Clay is interested in improving cancer victim’s lives. Currently, he serves as the company’s CEO, president and Chairman of the board. After attaining his PhD, he has tirelessly worked with various research departments. He began as a research investigator at Bristol- Myers Institute. Later elevated to the […]